| Ident. | Authors (with country if any) | Title |
|---|
| 000010 (2021) |
Nicole Fagan [Irlande (pays)] ; Nekma Meah [Australie] ; Katherine York [Afrique du Sud] ; Laita Bokhari [Australie] ; Godfrey Fletcher [Irlande (pays)] ; Gang Chen [Australie] ; Desmond J. Tobin [Irlande (pays)] ; Andrew Messenger [Royaume-Uni] ; Alan D. Irvine [Irlande (pays)] ; Rodney Sinclair [Australie] ; Dmitri Wall [Irlande (pays)] | Shedding light on therapeutics in alopecia and their relevance to COVID-19. |
| 000011 (2021) |
Matthieu Million [France] ; Audrey Giraud-Gatineau [France] ; Jean-Christophe Lagier [France] ; Philippe Parola [France] ; Philippe Gautret [France] ; Didier Raoult [France] | Reply to Lebeaux D, Revest M. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin. |
| 000022 (2021) |
E. Díaz [Espagne] ; R. Amézaga Menéndez [Espagne] ; P. Vidal Cortés [Espagne] ; M G Escapa [Espagne] ; B. Suberviola [Espagne] ; A. Serrano Lázaro [Espagne] ; P. Marcos Neira [Espagne] ; M. Quintana Díaz [Espagne] ; M. Catalán González [Espagne] | [Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH)]. |
| 000029 (2021) |
Maurizio Koch | [2020: Evidence-Based Medicine odyssey. The fall and rise of evidence-based medicine in the year of coronavirus.] |
| 000056 (2021) |
Jessica S C. Leung [Hong Kong] ; Maurice M W. Cheng [Nouvelle-Zélande] | Trust in the time of corona: epistemic practice beyond hard evidence. |
| 000078 (2021) |
Ales Janda [Allemagne] ; Catharina Schuetz [Allemagne] ; Scott Canna [États-Unis] ; Mark Gorelik [États-Unis] ; Maximilian Heeg [Allemagne] ; Kirsten Minden [Allemagne] ; Claas Hinze [Allemagne] ; Ansgar Schulz [Allemagne] ; Klaus-Michael Debatin [Allemagne] ; Christian M. Hedrich [Royaume-Uni] ; Fabian Speth [Allemagne] | Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists. |
| 000097 (2021) |
Jack Cook [États-Unis] ; Milton L. Pressler [États-Unis] ; Bharat Damle [États-Unis] ; Demissie Alemayehu [États-Unis] ; Charles A. Knirsch [États-Unis] | The Weight of Evidence From Electrophysiology, Observational, and Cardiovascular End Point Studies Demonstrates the Safety of Azithromycin. |
| 000099 (2021) |
Zelyn Lee [Canada] ; Craig R. Rayner [États-Unis, Australie] ; Jamie I. Forrest [Canada] ; Jean B. Nachega [Afrique du Sud, États-Unis, Canada] ; Esha Senchaudhuri [Canada] ; Edward J. Mills [Canada] | The Rise and Fall of Hydroxychloroquine for the Treatment and Prevention of COVID-19. |
| 000100 (2021) |
Rana Aljadeed [Arabie saoudite] | The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19. |
| 000104 (2021) |
Farah Daou [Liban] ; Gretta Abou-Sleymane [Liban] ; Danielle A. Badro [Liban] ; Nagham Khanafer [France] ; Mansour Tobaiqy [Arabie saoudite] ; Achraf Al Faraj [Liban] | The History, Efficacy, and Safety of Potential Therapeutics: A Narrative Overview of the Complex Life of COVID-19. |
| 000105 (2021) |
Nour K. Younis [Liban] ; Rana O. Zareef [Liban] ; Mohammad Ali N. Maktabi [Liban] ; Rami Mahfouz [Liban] | The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment. |
| 000107 (2021) |
O O Oleribe [Nigeria] ; P. Oskouipour [États-Unis] ; O. Nwanyanwu [États-Unis] ; S D Taylor-Robinson [Royaume-Uni] | The COVID-19 era: the view from Nigeria. |
| 000146 (2021) |
Rahul Sharma [Inde] ; Dharmendra Khokhar [Inde] ; Bhanushree Gupta [Inde] ; Purnendu Saxena [Inde] ; Kallol Kumar Ghosh [Inde] ; Arvind Kumar Geda [Inde] ; Kamil Kuca | Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2): A Review on Pathophysiology, Diagnosis and Investigational Therapeutics. |
| 000148 (2021) |
Jean Franco Quispe-Ca Ari [Pérou] ; Evelyn Fidel-Rosales [Pérou] ; Diego Manrique [Pérou] ; Jesús Mascar Zan [Pérou] ; Katia Medalith Huamán-Castill N [Pérou] ; Scherlli E. Chamorro-Espinoza [Pérou] ; Humberto Garayar-Peceros [Pérou] ; Vania L. Ponce-L Pez [Pérou] ; Jhesly Sifuentes-Rosales [Pérou] ; Aldo Alvarez-Risco [Pérou] ; Jaime A. Yá Ez [Pérou] ; Christian R. Mejia [Pérou] | Self-medication practices during the COVID-19 pandemic among the adult population in Peru: A cross-sectional survey. |
| 000169 (2021) |
Bianca D. Balmant [Brésil] ; Raquel S. Torrinhas [Brésil] ; Ilanna M. Rocha [Brésil] ; Danielle C. Fonseca [Brésil] ; Francisco F C. Formiga [Brésil] ; Eloisa S D O. Bonfá [Brésil] ; Eduardo F. Borba [Brésil] ; Dan L. Waitzberg [Brésil] | SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link? |
| 000223 (2021) |
Jessica M. Franklin [États-Unis] ; Kueiyu Joshua Lin [États-Unis] ; Nicolle M. Gatto [États-Unis] ; Jeremy A. Rassen [États-Unis] ; Robert J. Glynn [États-Unis] ; Sebastian Schneeweiss [États-Unis] | Real-World Evidence for Assessing Pharmaceutical Treatments in the Context of COVID-19. |
| 000227 (2021) |
Iwein Gyselinck [Belgique] ; Wim Janssens [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] | Rationale for azithromycin in COVID-19: an overview of existing evidence. |
| 000240 (2021) |
Clara Locher [France] ; David Moher [Canada] ; Ioana Alina Cristea [Italie] ; Florian Naudet [France] | Publication by association: how the COVID-19 pandemic has shown relationships between authors and editorial board members in the field of infectious diseases. |
| 000243 (2021) |
Wei Tang [États-Unis] ; Yevgeniya Gartshteyn [États-Unis] ; Cathy Guo [États-Unis] ; Tommy Chen [États-Unis] ; Jon Giles [États-Unis] ; Anca Askanase [États-Unis] | Prophylaxis of COVID-19 with Hydroxychloroquine and Chloroquine. |
| 000249 (2021) |
Bianza Moise Bakadia ; Feng He [République populaire de Chine] ; Tiatou Souho [Togo] ; Lallepak Lamboni [Togo] ; Muhammad Wajid Ullah [République populaire de Chine] ; Biaou Ode Boni [République populaire de Chine] ; Abeer Ahmed Qaed Ahmed [République populaire de Chine] ; Biampata Mutu Mukole ; Guang Yang [République populaire de Chine] | Prevention and treatment of COVID-19: Focus on interferons, chloroquine/hydroxychloroquine, azithromycin, and vaccine. |
| 000274 (2021) |
Jing Yuan [République populaire de Chine] ; Minghui Li [États-Unis] ; Yiqun Yu [République populaire de Chine] ; Tai-Ying Lee [États-Unis] ; Gang Lv [République populaire de Chine] ; Bing Han [République populaire de Chine] ; Xiaoqiang Xiang [République populaire de Chine] ; Z Kevin Lu [États-Unis] | Pharmacotherapy Management for COVID-19 and Cardiac Safety: A Data Mining Approach for Pharmacovigilance Evidence from the FDA Adverse Event Reporting System (FAERS). |
